UnknownNot Applicable

Impact of Gluten Contamination in Celiac Patients Clinically Responsive and Unresponsive to the Gluten-free Diet

Italy300 participantsStarted 2019-02-01

Plain-language summary

The primary aim of the study is to detect the presence of gluten immunogenic peptides (GIP) in urine samples from celiac patients on a gluten-free diet clinically responsive and non-responsive to dietary treatment and from suspected celiac patients already on a gluten-free diet.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age: 18 to 65 years old * Gender: Males and Females * Patients: suffering from Celiac Disease and suspected, but already on a gluten-free diet Exclusion Criteria: * Celiac patients less than 6 months after diagnosis * Celiac patients reporting intentional gluten ingestion

What they're measuring

GIP

Timeframe: 3 weeks

Trial details

NCT IDNCT05066191

SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-01

Contact for this trial

Maurizio Vecchi, MD

0255033418 maurizio.vecchi@policlinico.mi.it

View on ClinicalTrials.gov More Celiac Disease trials